DNMT3B and breast carcinoma: We hypothesized that overexpression of DNMT3B in breast cancer could lead to aberrant (ectopic) DNA methylation of multiple regions of the genome in tumour cells, which would abnormally reduce the expression of certain genes that are normally expressed in healthy breast tissue.